Balovaptan is under investigation in clinical trial NCT01793441 (A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.